InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Wednesday, 10/26/2016 8:08:44 PM

Wednesday, October 26, 2016 8:08:44 PM

Post# of 48316
Merck sales of Keytruda are just getting started. Sales of Keytruda are expected to hit $3 Billion in 2017. That is a 100% growth rate in the next year. That will double again by 2020 to roughly $6 Billion. Logically what would the next best road to travel be for expansion of Keytruda and pump those sales up beyond belief?.....Addressing the 70% of patients that do not respond to Keytruda monotherapy. Big market opportunity here for Oncosec. Right place, right time. You never know, Merck might open up that wallet after Nov. 11th to lock this down. Hoping. Go Oncosec!